In August, Johnathon Seth Parham, MD and Anne Carol Goldberg, MD, FACP had their review titled “Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know,” published in “Current Atherosclerosis Reports.” The review looks at two new lipid-lowering treatment medications, bempedoic acid and inclisiran. “Bempedoic acid inhibits adenosine citrate lyase, decreasing […]
Parham and Goldberg publish review on bempedoic acid and inclisiran treatment
